Education

Education

Education

The Ozempic Shortage Explained

Written by

SmithRx

Nov 16, 2023

Aspect ratio controlled image
Aspect ratio controlled image
Aspect ratio controlled image

Ozempic, manufactured by Novo Nordisk, is a medication FDA approved for treatment of type 2 diabetes. An uptick in off-label prescription use, for indications such as Obesity, has led to an increase in demand for Ozempic. The high demand has resulted in an Ozempic shortage nationwide. The manufacturer has indicated the shortage will continue until December 2022.

Social media platform, TikTok, has also seen an uptick in hashtags and views related to Ozempic. As of September 2022, #Ozempic has 185.6 million views, and the hashtag #OzempicWeightLoss with 69.9 million views.

It’s important our members continue to manage their blood glucose levels to prevent long-term complications from diabetes. SmithRx is available to support our members and clients in navigating the short supply. We have sent mailers to potentially impacted members and provided covered, formulary alternatives and proactive measures to ensure members have enough medication on hand.

Share

Share

Written by

SmithRx

SmithRx is the #1 Modern PBM, relentlessly focused on eliminating the conflicts and complexity of legacy pharmacy benefits. Built on radical transparency and fiduciary alignment, we empower employers to take control of their pharmacy spend and experience with our 100% pass-through model.

SmithRx Logo

SmithRx is on a mission to reduce the complexity and costs of pharmacy benefits with radical transparency and cutting-edge technology.

© 2025 Smith Health, Inc
SmithRx Logo

SmithRx is on a mission to reduce the complexity and costs of pharmacy benefits with radical transparency and cutting-edge technology.

© 2025 Smith Health, Inc
SmithRx Logo

SmithRx is on a mission to reduce the complexity and costs of pharmacy benefits with radical transparency and cutting-edge technology.

Awards

Company

Resources

Connect

© 2025 Smith Health, Inc